| Report ID | 244055 |
| Drug Identification Number | 02473879 |
| Brand name | GLYCOPYRROLATE INJECTION USP |
| Common or Proper name | GLYCOPYRROLATE INJECTION USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GLYCOPYRROLATE |
| Strength(s) | 0.2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR |
| Packaging size | PACK OF 10 VIALS 1 mL |
| ATC code | A03AB |
| ATC description | DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2024-12-13 |
| Actual start date | |
| Estimated end date | 2026-02-27 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-01-08 |
| Company comments | Contract coverage confirmed until end of January 2026. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v31 | 2026-01-08 | French | Compare |
| v30 | 2026-01-08 | French | Compare |
| v29 | 2026-01-08 | English | Compare |
| v28 | 2025-12-04 | French | Compare |
| v27 | 2025-12-04 | English | Compare |
| v26 | 2025-11-13 | French | Compare |
| v25 | 2025-11-13 | English | Compare |
| v24 | 2025-10-30 | French | Compare |
| v23 | 2025-10-30 | English | Compare |
| v22 | 2025-09-12 | French | Compare |
| v21 | 2025-09-12 | English | Compare |
| v20 | 2025-08-28 | French | Compare |
| v19 | 2025-08-28 | English | Compare |
| v18 | 2025-06-25 | French | Compare |
| v17 | 2025-06-25 | English | Compare |
| v16 | 2025-06-11 | French | Compare |
| v15 | 2025-06-11 | English | Compare |
| v14 | 2025-04-10 | French | Compare |
| v13 | 2025-04-10 | English | Compare |
| v12 | 2025-03-20 | French | Compare |